(Total Views: 165)
Posted On: 05/24/2022 11:40:53 AM
Post# of 104867
$CASI News Article - CASI PHARMACEUTICALS ENTERES INTO SUBLICENSE AGREEMENT WITH TIANSHI PHARMACEUTICALS FOR ANTI-CD38 MONOCLONAL ANTIBODY (MAB) CID-103 IN AUTOIMMUNE FIELD https://marketwirenews.com/news-releases/casi...46845.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
